Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 2
2005 6
2006 6
2007 8
2008 10
2009 13
2010 15
2011 8
2012 8
2013 9
2014 9
2015 8
2016 9
2017 7
2018 10
2019 12
2020 12
2021 14
2022 13
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination.
Strezova A, Diez-Domingo J, Al Shawafi K, Tinoco JC, Shi M, Pirrotta P, Mwakingwe-Omari A; Zoster-049 Study Group. Strezova A, et al. Open Forum Infect Dis. 2022 Oct 23;9(10):ofac485. doi: 10.1093/ofid/ofac485. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36299530 Free PMC article.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng HS, Cheong HJ, Choo EJ, Curiac D, Di Paolo E, Dionne M, Eckermann T, Esen M, Ferguson M, Ghesquiere W, Hwang SJ, Avelino-Silva TJ, Kosina P, Liu CS, Markkula J, Moeckesch B, Murta de Oliveira C, Park DW, Pauksens K, Pirrotta P, Plassmann G, Pretswell C, Rombo L, Salaun B, Sanmartin Berglund J, Schenkenberger I, Schwarz T, Shi M, Ukkonen B, Zahaf T, Zerbini C, Schuind A, Cunningham AL; Zoster-049 Study Group. Boutry C, et al. Clin Infect Dis. 2022 Apr 28;74(8):1459-1467. doi: 10.1093/cid/ciab629. Clin Infect Dis. 2022. PMID: 34283213 Free PMC article. Clinical Trial.
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G, Lorenzen JM, Ma H, de Haan N, Seeger H, Zaghrini C, Brandt S, Kölling M, Wegmann U, Kiss B, Pál G, Gál P, Wüthrich RP, Wuhrer M, Beck LH, Salant DJ, Lambeau G, Kistler AD. Haddad G, et al. Among authors: gal p. J Clin Invest. 2021 Mar 1;131(5):e140453. doi: 10.1172/JCI140453. J Clin Invest. 2021. PMID: 33351779 Free PMC article.
Proprotein Convertases and the Complement System.
Dobó J, Kocsis A, Dani R, Gál P. Dobó J, et al. Among authors: gal p. Front Immunol. 2022 Jul 6;13:958121. doi: 10.3389/fimmu.2022.958121. eCollection 2022. Front Immunol. 2022. PMID: 35874789 Free PMC article. Review.
Evolution of Cancer Progression in the Context of Darwinism.
Lacina L, Čoma M, Dvořánková B, Kodet O, Melegová N, Gál P, Smetana K Jr. Lacina L, et al. Among authors: gal p. Anticancer Res. 2019 Jan;39(1):1-16. doi: 10.21873/anticanres.13074. Anticancer Res. 2019. PMID: 30591435 Review.
MASP-1 Increases Endothelial Permeability.
Debreczeni ML, Németh Z, Kajdácsi E, Schwaner E, Makó V, Masszi A, Doleschall Z, Rigó J, Walter FR, Deli MA, Pál G, Dobó J, Gál P, Cervenak L. Debreczeni ML, et al. Among authors: gal p. Front Immunol. 2019 May 3;10:991. doi: 10.3389/fimmu.2019.00991. eCollection 2019. Front Immunol. 2019. PMID: 31130964 Free PMC article.
Soy and breast cancer: focus on angiogenesis.
Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J. Varinska L, et al. Among authors: gal p. Int J Mol Sci. 2015 May 22;16(5):11728-49. doi: 10.3390/ijms160511728. Int J Mol Sci. 2015. PMID: 26006245 Free PMC article. Review.
184 results